Applied Biosystems Advanced Gene Expression Service Provider Program Expands Globally; Researchers in North America, Europe, and Asia Outsource Comprehensive Gene Expression Analysis Using Applied Biosystems Expression Array System.FOSTER CITY, Calif. -- Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. (NYSE NYSE See: New York Stock Exchange :ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. ), an Applera Corporation business, today announced its Advanced Gene Expression Service Provider Program has expanded globally with the addition of eleven microarray service provider centers throughout North America, Europe, and Asia. As part of their participation, the eleven companies and academic centers will offer Applied Biosystems microarray gene expression tools and services, including microarrays for human, mouse, and rat genes to enhance service providers' business offerings. The Program also includes technical support that is expected to enhance their ability to deliver advanced gene expression services to clients. Researchers taking advantage of the microarray services will have the option to validate data from the Applied Biosystems microarrays using Applied Biosystems TaqMan(R) Gene Expression Assays and Real-Time PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) Systems. "Microarray analysis is a major area of focus for our institution," said Shawn Levy, Ph.D., Director, Vanderbilt Microarray Shared Resource at Vanderbilt University. "Participation in the Program will allow us to make strategic investment in our gene expression technology platform and realize a significant return through a service that will provide our researchers access to the most annotated gene content available and the highest-quality results." "Applied Biosystems offers the broadest gene expression portfolio," added Mirko Vanetti, Ph.D., CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of IMGM Laboratories and one of the first Program collaborators. "We have already seen initial success with the Applied Biosystems Expression Array System offerings which allows us to combine our medical expertise with some of the best technologies available on the market. For example, the tools offered in the Program are helping us identify customer gene signatures that may ultimately lead to a diagnostic test for Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. ." The latest additions to Applied Biosystems Advanced Gene Expression Service Provider Program include: Bionomics bi·o·nom·ics n. (used with a sing. verb) See ecology. [From French bionomique, pertaining to ecology, from bionomie, ecology : Greek bio-, bio- Research and Technology Center at the University of Medicine and Dentistry of New Jersey The University of Medicine and Dentistry of New Jersey is the state-run health sciences institution of New Jersey and comprises eight distinct academic units: the New Jersey Medical School, the New Jersey Dental School, the Graduate School of Biomedical Sciences, the School of and Rutgers University (USA); Geneservice Limited (UK); Genome Express (France); IMGM Laboratories (Germany); Labindia (India); Macrogen (South Korea); Center for Medical Research, Medical University Graz (Austria); Ming Shin Biotech (Taiwan); Trinity College Dublin (Ireland); Norwegian Microarray Consortium, University of Bergen The University of Bergen (Universitetet i Bergen) is located in Bergen, Norway. Although founded as late as 1946, academic activity had taken place at Bergen Museum as far back as 1825. The university today caters for more than 16,000 students. (Norway); and Vanderbilt Shared Microarray Resource (USA). To access a complete list of Applied Biosystems gene expression service providers by region, visit http://www.microarrayservices.com. "Applied Biosystems is pleased to announce the expansion of our Advanced Gene Expression Service Provider Program with the addition of service providers from around the globe," said William V. Murray, Division President of Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller for Applied Biosystems. "Through this program, these companies and academic centers can confidently offer clients the most complete gene content for microarray expression analysis while backing it up with technical and marketing support from a leading provider of gene expression technologies." Additional data analysis and marketing support is included with the Applied Biosystems Advanced Gene Expression Service Provider Program. Participants will have access to the PANTHER(TM) Protein Classification System, a Service Provider web link on the Applied Biosystems Website, marketing collateral material development, and educational seminars. About Applied Biosystems Expression Array System The Applied Biosystems Expression Array System is a highly sensitive gene expression detection system with capabilities to detect many genes due to improved signal to noise capability. Applied Biosystems microarrays offer fully annotated and manually curated gene sets for human, mouse and rat, designed from both public and Celera databases. The system uses a chemiluminescence-detection instrument, software, and chemistries to deliver unambiguous, highly sensitive, and reproducible gene results. About Applera Corporation and Applied Biosystems Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids Nucleic acids The cellular molecules DNA and RNA that act as coded instructions for the production of proteins and are copied for transmission of inherited traits. (DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic ), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing paternity testing see parentage testing. ); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of nearly $1.8 billion during fiscal 2005. The Celera Genomics Group is focused on discovery, development, and commercialization of diagnostic products as well as leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com. Applied Biosystems Forward-Looking Statements Certain statements in this press release are forward-looking. These may be identified by the use of forward-looking words or phrases such as "should," "expect," and "planned," among others. These forward-looking statements are based on Applera Corporation's current expectations. The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 provides a "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " for such forward-looking statements. In order to comply with the terms of the safe harbor, Applera Corporation notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These factors include but are not limited to: (1) rapidly changing technology and dependence on the development and customer acceptance of new products; (2) sales dependent on customers' capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. policies and government-sponsored research; (3) Applied Biosystems' dependence on the operation of computer hardware, software, and Internet applications and related technology; and (4) other factors that might be described from time to time in Applera Corporation's filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information, including any forward-looking statements, unless required by law. For Research Use Only. Not for use in diagnostic procedures. The PCR process and 5' nuclease nuclease /nu·cle·ase/ (noo´kle-as) any of a group of enzymes that split nucleic acids into nucleotides and other products. nu·cle·ase n. process are covered by patents owned by Roche Molecular Systems, Inc. and F. Hoffmann-La Roche Ltd, and by patents owned by or licensed to Applera Corporation. Further information on purchasing licenses, including for real-time PCR commercial services or other applied fields, may be obtained from the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California
Copyright(C) 2006. Applied Biosystems. All rights reserved. Applied Biosystems and Celera are registered trademarks and Applera, Celera Diagnostics, Celera Genomics, Celera Discovery System, and PANTHER are trademarks of Applera Corporation or its subsidiaries in the US and/or certain other countries. TaqMan is a registered trademark of Roche Molecular Systems, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion